Protara Therapeutics Inc reports results for the quarter - Earnings Summary

Protara Therapeutics

12/11/2024 15:32

* Protara Therapeutics Inc  TARA.OQ  reported a quarterly
adjusted
loss of 50 cents​​ per share for the quarter , higher than the
same quarter last year, when the company reported EPS of -87
cents.  The mean expectation of four analysts for the quarter
was for a loss of 52 cents per share. Wall Street expected
results to range from -56 cents to -48 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Protara Therapeutics Inc's reported EPS for the quarter
was a
loss of 50 cents​.
    * The company reported a quarterly loss of $11.22 million.
    * Protara Therapeutics Inc shares had risen by 41.0% this
quarter and gained 37.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Protara
Therapeutics Inc is $23.00 
This summary was machine generated from LSEG data November 12 at
03:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.52          -0.50          Beat
 Jan. 1 0001       -0.80          -0.45          Beat
 Mar. 31 2024      -0.92          -0.97          Missed
 Dec. 31 2023      -0.92          -0.90          Beat